Consistent with such data, we assessed by immunohistochemistry analysis and via Masson’s trichrome staining, significantly decreased levels of SMAD3 and αSMA+/S100A4+ molecules and a significantly reduced rate of fibrosis in tissue aorta samples from BAV cases with AAA when compared with TAV cases. This evidence concerns the gene SMAD3 and triple-A syndrome.